Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MADD antibody (C-Term)

The Rabbit Polyclonal anti-MADD antibody has been validated for WB, IF and EIA. It is suitable to detect MADD in samples from Human, Mouse and Rat.
Catalog No. ABIN500216

Quick Overview for MADD antibody (C-Term) (ABIN500216)

Target

See all MADD Antibodies
MADD (MAP-Kinase Activating Death Domain (MADD))

Reactivity

  • 32
  • 23
  • 16
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Mouse, Rat

Host

  • 39
Rabbit

Clonality

  • 38
  • 1
Polyclonal

Conjugate

  • 18
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This MADD antibody is un-conjugated

Application

  • 15
  • 15
  • 13
  • 10
  • 7
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Enzyme Immunoassay (EIA)
  • Binding Specificity

    • 15
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term

    Specificity

    This antibody detects MADD at C-term.

    Cross-Reactivity (Details)

    Species reactivity (tested):Human, mouse, rat

    Purification

    DEAE purified

    Immunogen

    MADD antibody was raised against a peptide corresponding to amino acids near the carboxy terminus of human MADD.

    Isotype

    IgG
  • Application Notes

    ELISA. Western blot: 1: 250 - 1: 500 dilution, 200 to 220 kDa bands should be detected. Immunocytochemistry.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Restrictions

    For Research Use only
  • Buffer

    PBS containing 0.02 % sodium azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Avoid repeated freezing and thawing.

    Storage

    4 °C/-20 °C

    Storage Comment

    Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.
  • Target

    MADD (MAP-Kinase Activating Death Domain (MADD))

    Alternative Name

    MADD

    Background

    MAP kinase-activating death domain protein (MADD) was initially identified as the type 1 tumor necrosis factor receptor (TNFR1) associated protein though their death domains. Overexpression of MADD activates MAP kinases ERK and JNK and induces the phosphorylation of cytosolic phospholipase A2. MADD shares 98 % identity with DENN (for differentially expressed in neoplastic vs. normal cells), which was recently identified as a substrate for c-jun N-terminal kinase 3 (JNK3). MADD has greater than 94 % overall identity to a GDP/GTP exchange protein Rab3-GEP. MADD is 87 % identical to KIAA0358, a brain protein of unknown function. Identification of MADD as a component of the TNFR1 signaling complex and the similarity between MADD and Rab3-GEP provides a connection between TNFR1 activation and downstream MAP kinase activity through a guanine-nucleotide exchange protein.Synonyms: DENN, IG20, MAP kinase-activating death domain protein, RAB3GEP, Rab3 GDP/GTP exchange factor

    Gene ID

    8567

    UniProt

    Q8WXG6

    Pathways

    Caspase Cascade in Apoptosis
You are here:
Chat with us!